We combined the info from standard and neoplastic samples from our most cancers clients which has a the latest dataset from regular crypts of balanced patients9, and done mutational signature discovery employing SparseSignature20, a way that avoids overfitting of signatures by enforcing sparsity with the signal (Supplementary Fig. 3). We acquired